Tryvio™ (aprocitentan) – New drug approval
March 20, 2024 - Idorsia announced the FDA approval of Tryvio (aprocitentan), in combination with other antihypertensive drugs, for the treatment of hypertension, to lower blood pressure in adult patients who are not adequately controlled on other drugs.
Download PDF
